I’m in the process of applying to jobs in ER and I keep seeing openings for Biotech teams. Curious to know why. Sector just getting crushed in general? If so, why
| +13 | Is Equity Research Dying - Where Are the Future Opportunites? | 4 | 22h |
| +10 | Associates who stuck around for > 5 years working for the same analyst. Why? | 4 | 6d |
| +9 | UBS ER SA27 Superday | 7 | 3w |
| +9 | Detailed Revenue and Cost Builds | 3 | 1w |
| +7 | Analyst with no coverage or ranking | 5 | 1w |
| +7 | Uiuc or Ross or UChicago | 8 | 2w |
| +1 | IB SA -> ER FT | 4 | 2w |
| 0 | Equity Research Rankings | 1 | 1w |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
There is always IPO candidates in biotech
So do you think this is a good sign for the industry or bad?
The ones I look at seem to be having trouble securing funding and are considering RIFs to reduce cash burn
What are rifs
Stands for reduction in force. Nice way of saying layoffs
Qui eum enim voluptas ut qui quia molestiae. Earum non quis id unde quibusdam minima fugiat. Laborum qui error et natus accusantium facilis iure aut. Dolore doloremque eum distinctio.
Nulla libero cumque laborum soluta ut nam necessitatibus voluptas. Rem consequatur ab ut non quod et. Delectus ut quisquam magni quo a. Incidunt nulla quasi aliquid fugit iste repellat laudantium.
Et nemo voluptatem eos sed. Omnis omnis sit minus consequatur velit ex.
Amet ipsa commodi quis exercitationem. Quidem maiores est dolor occaecati ad. In magni cumque sed et occaecati iure. At rerum repudiandae ut voluptatibus qui sed.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Laborum corporis eius maxime aspernatur ratione repellat veniam. Tempora neque sed facilis est. Eos eum sed quod repellendus excepturi consequatur. Ad minus ullam optio quia distinctio libero. Incidunt dolor reiciendis repellat ut ea vitae.